1 / 2

How AI is Used for in this German Drug Research Startup

OncoCoin AG is a Swiss-based company and a wholly owned subsidiary of the international AI and Blockchain-based Drug Discovery and Development company Innoplexus AG. OncoCoin AG is mainly known for initiating the world's largest Pancreatic Cancer Biomarker Study (PALAS study) led by European Pancreatic Cancer experts.<br>https://amrit.ai/

jackmethyu
Download Presentation

How AI is Used for in this German Drug Research Startup

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. How AI is Used in this German Drug Research Startup OncoCoin AG is a Swiss-based company and a wholly owned subsidiary of the international AI and Blockchain-based Drug Discovery and Development company Innoplexus AG. OncoCoin AG is mainly known for initiating the world’s largest Pancreatic Cancer Biomarker Study (PALAS study) led by European Pancreatic Cancer experts. OncoCoin AG also runs a free mobile app for cancer patients called the CURIA App that helps cancer patients identify people with similar symptoms, reach out to doctors for second opinions and identify clinical trials. Furthermore, OncoCoin AG introduced one of the world’s largest decentralised and GDPR-compliant Real World Data (RWD) exchange, dubbed the AMRIT tokens, to help patients pay for services such as independent second opinion, access to digital

  2. therapeutics and more. This utility token enables patients to reclaim ownership and benefit from revenues derived from their data. In an exclusive interview with Analytics India Magazine, Ashwinkumar Rathod, Co-CEO & Co-Founder, OncoCoin, sheds light on how they embed ethics into their products. To Know More Click Below https://amrit.ai/

More Related